Are MRAs the Secret Weapon Against Hormonal Hypertension?

The Role of MRAs in Treatment

MRAs like spironolactone and eplerenone are key players in treating primary aldosteronism, especially for those who cannot undergo surgery. These drugs block the effects of aldosterone, helping to regulate blood pressure and potassium levels. They are often the first-line treatment for bilateral adrenal disease.

Choosing Between Spironolactone and Eplerenone

Spironolactone is the go-to choice due to its effectiveness and affordability, but it can cause side effects like breast tenderness. Eplerenone is more selective and has fewer side effects but is generally more expensive. Patients often start with spironolactone and switch to eplerenone if needed.

Monitoring and Adjusting Treatment

Regular monitoring of blood pressure, potassium, and creatinine levels is crucial when using MRAs. Adjustments to dosage may be necessary to achieve optimal results. Monitoring helps avoid potential side effects and ensures the treatment is effective.

Frequently Asked Questions

Key Takeaways

Could MRAs be the key to controlling your aldosterone-driven hypertension?

Related Articles

• Could Your High Blood Pressure Be Caused by Primary Aldosteronism?
• Can Surgery Cure Your Hormonal High Blood Pressure?
• Preventing the Silent Killer: How to Tackle Primary Aldosteronism Early
• Managing Primary Aldosteronism During Pregnancy: What You Need to Know

References